Results 191 to 200 of about 142,779 (351)

Exploring patients' perceptions and anticipated concerns regarding bariatric surgery. [PDF]

BMC Surg
Chen X, Cai CZ, Yang N, Zhou L, Yang H, Hua H, Song Y, Alias H, Huang Z, Wong LP, Lin Y.   +10 more
europepmc   +1 more source

Is AMP‐activated protein kinase activation a central mechanism of cardio‐metabolic outcomes after metabolic and bariatric surgery?

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Metabolic and bariatric surgery (MBS) is the most effective treatment for severe obesity. It usually results in spectacular weight loss, associated with improvements of obesity‐associated comorbidities. The mechanisms underlying these benefits are not fully understood but could involve a postoperative activation of the enzyme 5′ AMP‐activated ...
Adrien Delcour, Nathalie Niederhoffer
wiley   +1 more source

Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity

Periodontology 2000, EarlyView., 2023
Abstract Noncommunicable diseases (NCDs) are multifactorial, long‐term, chronic conditions that represent a burden to health‐care systems worldwide as they can only be controlled rather than cured; hence, they require long‐term care. With the exponential increase in NCDs, the occurrence of individuals presenting with more than one chronic disease is ...
Crystal Marruganti, Jean E. Suvan, Francesco D'Aiuto   +2 more
wiley   +1 more source

Training pathways and formal curricula in robotic bariatric surgery: a systematic review. [PDF]

J Robot Surg
Brucchi F, Zhang D, Bertoli S, Colosimo S, Dionigi G.   +4 more
europepmc   +1 more source

Triple thrombophilic simultaneous mutations in patients after bariatric surgery: is there a role for screening in the Eastern Mediterranean?

, 2018
Hussein Nassar, Ahmad Zaghal, Alì Taher, Rami Mahfouz, Bassem Safadi, Mariam Kanso, Mohammad Khalife, Walid Faraj   +7 more
openalex   +1 more source

Treatment of obesity and diabetes with bariatric surgery [PDF]

, 2013
Kevin Whitlock, Richdeep S. Gill, Noah Switzers, Daniel W. Birch, Shahzeer Karmali   +4 more
openalex   +1 more source

Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX‐SEMA 2.4 mg, an Italian real‐world study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate real‐world clinical use of semaglutide in obese patients, focusing on titration, tolerability and short‐term efficacy. Materials and Methods This retrospective study included obese patients treated with the weekly injectable semaglutide.
Simone Pampanelli, Stefano Terzoni, Paola Pantanetti, Chiara Di Loreto, Alessio Mazzieri, Giovanni Cangelosi, Sara Alberti, Cristina Badiali, Ilenia Grandone, Sara Migliarelli, Maria Grazia Castagna, Mariaclaudia Cerrai Ceroni, Nicoletta Benenati   +12 more
wiley   +1 more source

Remission of hypothyroidism in post-bariatric surgery patients. [PDF]

Qatar Med J
Mahmood Buhary B, Alshehri A, Abukhater M, Mahmood WN, Mahmood SF.   +4 more
europepmc   +1 more source

Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD), characterised by hepatic steatosis and metabolic dysfunction (i.e., obesity, type 2 diabetes, dyslipidaemia, and hypertension), is affecting over 30% of the adult population worldwide.
Lanlan Chen, Paul Horn, Frank Tacke
wiley   +1 more source

Perspectives of Patients Seeking Bariatric Surgery: The Impact of Early Patient-Provider Communication on Bariatric Surgery Utilization. [PDF]

Obes Surg
Srinivasan N, Samaan J, Rajeev N, Premkumar A, Alvarez K, Harvey L, Nguyen S, Tran A, Samakar K.   +8 more
europepmc   +1 more source